Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
197M
-
Number of holders
-
1009
-
Total 13F shares, excl. options
-
186M
-
Shares change
-
+2.29M
-
Total reported value, excl. options
-
$29.8B
-
Value change
-
+$371M
-
Put/Call ratio
-
0.44
-
Number of buys
-
406
-
Number of sells
-
-413
-
Price
-
$160.08
Significant Holders of ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) as of Q1 2021
1,112 filings reported holding ZBH - ZIMMER BIOMET HOLDINGS, INC. - Common Stock as of Q1 2021.
ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) has 1,009 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 186M shares
of 197M outstanding shares and own 94.46% of the company stock.
Largest 10 shareholders include BlackRock Inc. (20.9M shares), VANGUARD GROUP INC (15.9M shares), Capital Research Global Investors (10.4M shares), JPMORGAN CHASE & CO (8.96M shares), STATE STREET CORP (8.33M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.13M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (4.31M shares), Nuveen Asset Management, LLC (4.1M shares), VIKING GLOBAL INVESTORS LP (3.82M shares), and Capital International Investors (3.53M shares).
This table shows the top 1009 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.